Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
INDUSTRY
×
Bortezomib
×
Clear all
Filters
3
NCT07428369
2026-02-23
LINKER-MM8
Regeneron Pharmaceuticals
Phase 2/3
Not yet recruiting
1,570 enrolled
NCT00514371
2015-12-07
TIME-2
Bristol-Myers Squibb
Phase 2/3
Completed
22 enrolled